Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 28 | 29 | 28 | 28 | 28 |
| Accounts receivable | -230 | -60 | -77 | -11 | 57 |
| Accounts payable and accrued liabilities | -4 | 32 | -7 | -31 | -43 |
| Other Working Capital | -183 | -3 | -90 | -38 | -30 |
| Other Operating Activity | -429 | -679 | -470 | -661 | -664 |
| Operating Cash Flow | $-818 | $-682 | $-615 | $-714 | $-653 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -6 | -14 | -14 | 0 | -6 |
| Other Investing Activity | 0 | 0 | 7 | 0 | 0 |
| Investing Cash Flow | $-6 | $-14 | $-7 | $0 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2 | N/A | N/A | N/A |
| Common Stock Issued | 0 | -47 | 1,888 | 120 | 707 |
| Other Financing Activity | 0 | 0 | 29 | 0 | 0 |
| Financing Cash Flow | $0 | $-45 | $1,916 | $120 | $707 |
| Beginning Cash Position | 1,294 | 2,034 | 740 | 1,333 | 1,285 |
| End Cash Position | 525 | 1,294 | 2,034 | 740 | 1,333 |
| Net Cash Flow | $-768 | $-740 | $1,294 | $-593 | $48 |
| Free Cash Flow | |||||
| Operating Cash Flow | -818 | -682 | -615 | -714 | -653 |
| Capital Expenditure | -6 | -14 | -14 | 0 | -6 |
| Free Cash Flow | -824 | -696 | -629 | -714 | -659 |